Galectin Therapeutics Inc.
US ˙ NasdaqCM ˙ US3632252025

SecurityGALT / Galectin Therapeutics Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership84,000 shares
Latest Disclosed Value $ 234,360
Simplex Trading, Llc ownership in GALT / Galectin Therapeutics Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 84,000 shares of Galectin Therapeutics Inc. (US:GALT) valued at $234,360 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 5,579 shares of Galectin Therapeutics Inc.. This represents a change in shares of 1,405.65% during the quarter. The current value of the position is $197,400 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (GALT) in the form of stock options. The firm currently holds call options representing 62,200 of underlying shares valued at $173,538 USD and put options representing 7,300 of underlying shares valued at $20,367 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GALT / Galectin Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GALECTIN THERAPEUTICS COM 363225202 84,000 78,421 1,405.65 234 917.39 0.0001
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS COM 363225202 5,579 -61,761 -91.72 23 0.0000
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS COM 363225202 67,340 22,646 50.67 0 0.0001
2025-08-05 2025-06-30 13F GALECTIN THERAPEUTICS COM 363225202 44,694 43,915 5,637.36 0 0.0001
2025-05-12 2025-03-31 13F GALECTIN THERAPEUTICS COM 363225202 779 -17,205 -95.67 0 0.0000
2025-02-11 2024-12-31 13F GALECTIN THERAPEUTICS COM 363225202 17,984 8,194 83.70 0 0.0000
2024-11-08 2024-09-30 13F GALECTIN THERAPEUTICS COM 363225202 9,790 -1,564 -13.77 0 0.0000
2024-07-25 2024-06-30 13F GALECTIN THERAPEUTICS COM 363225202 11,354 3,477 44.14 0 0.0000
2024-04-25 2024-03-31 13F GALECTIN THERAPEUTICS COM 363225202 7,877 917 13.18 0 0.0000
2024-02-02 2023-12-31 13F GALECTIN THERAPEUTICS COM 363225202 6,960 -3,737 -34.94 0 0.0000
2023-11-01 2023-09-30 13F GALECTIN THERAPEUTICS COM 363225202 10,697 1,883 21.36 0 0.0000
2023-08-04 2023-06-30 13F GALECTIN THERAPEUTICS COM 363225202 8,814 817 10.22 0 0.0000
2023-04-27 2023-03-31 13F GALECTIN THERAPEUTICS COM 363225202 7,997 -11,726 -59.45 0 0.0000
2023-02-02 2022-12-31 13F GALECTIN THERAPEUTICS COM 363225202 19,723 9,293 89.10 0 -100.00 0.0000
2022-11-04 2022-09-30 13F GALECTIN THERAPEUTICS COM 363225202 10,430 -17,441 -62.58 17 -52.78 0.0000
2022-08-03 2022-06-30 13F GALECTIN THERAPEUTICS COM 363225202 27,871 14,930 115.37 36 80.00 0.0000
2022-05-02 2022-03-31 13F GALECTIN THERAPEUTICS COM 363225202 12,941 8,635 200.53 20 150.00 0.0000
2022-02-23 2021-12-31 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 4,306 4,306 8 0.0000
2021-08-12 2021-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -3,910 -100.00 0 -100.00
2021-04-26 2021-03-31 13F GALECTIN THERAPEUTICS COM 363225202 3,910 3,851 6,527.12 8 0.0000
2021-02-02 2020-12-31 13F GALECTIN THERAPEUTICS COM 363225202 59 59 -98.49 0 -100.00 0.0000
2020-07-13 2020-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -1,744 -100.00 0 -100.00
2020-04-29 2020-03-31 13F GALECTIN THERAPEUTICS COM 363225202 1,744 1,744 3 0.0000
2019-10-15 2019-09-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -986 -100.00 0 -100.00
2019-07-26 2019-06-30 13F GALECTIN THERAPEUTICS COM 363225202 986 986 4 0.0000
2019-04-18 2019-03-31 13F GALECTIN THERAPEUTICS COM 363225202 0 -7,727 -100.00 0 -100.00
2019-01-16 2018-12-31 13F GALECTIN THERAPEUTICS COM 363225202 7,727 4,208 119.58 26 23.81 0.0001
2018-10-23 2018-09-30 13F GALECTIN THERAPEUTICS COM 363225202 3,519 3,519 -54.46 21 -19.23 0.0001
2018-07-30 2018-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -1,315 -100.00 0 -100.00
2018-04-26 2018-03-31 13F GALECTIN THERAPEUTICS COM 363225202 1,315 -3,695 -73.75 6 -62.50 0.0003
2018-01-10 2017-12-31 13F GALECTIN THERAPEUTICS COM 363225202 5,010 -23,677 -82.54 16 -73.77 0.0007
2017-10-25 2017-09-30 13F GALECTIN THERAPEUTICS COM 363225202 28,687 28,687 61 0.0025
2016-10-07 2016-09-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -8,483 -100.00 0 -100.00
2016-07-18 2016-06-30 13F GALECTIN THERAPEUTICS COM 363225202 8,483 -498 -5.55 12 0.00 0.0008
2016-04-14 2016-03-31 13F GALECTIN THERAPEUTICS COM 363225202 8,981 702 8.48 12 -7.69 0.0010
2016-01-20 2015-12-31 13F GALECTIN THERAPEUTICS COM 363225202 8,279 8,229 16,458.00 13 8.33 0.0010
2015-10-08 2015-09-30 13F GALECTIN THERAPEUTICS COM 363225202 50 50 -99.40 0 -100.00 0.0000
2015-07-08 2015-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -2,274 -100.00 0 -100.00
2015-04-21 2015-03-31 13F GALECTIN THERAPEUTICS COM 363225202 2,274 -4,829 -67.99 7 -72.00 0.0008
2015-03-04 2014-12-31 13F GALECTIN THERAPEUTICS COM 363225202 7,103 7,103 25 0.0030
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F GALECTIN THERAPEUTICS CALL Call 62,200 -45.63 174 -63.58 n/a n/a n/a
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS CALL Call 114,400 535.56 476 n/a n/a n/a
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS CALL Call 18,000 18.42 0 n/a n/a n/a
2025-08-05 2025-06-30 13F GALECTIN THERAPEUTICS CALL Call 15,200 -29.30 0 n/a n/a n/a
2025-05-12 2025-03-31 13F GALECTIN THERAPEUTICS CALL Call 21,500 -75.12 0 n/a n/a n/a
2025-02-11 2024-12-31 13F GALECTIN THERAPEUTICS CALL Call 86,400 -7.79 0 n/a n/a n/a
2024-11-08 2024-09-30 13F GALECTIN THERAPEUTICS CALL Call 93,700 1,667.92 0 n/a n/a n/a
2024-07-25 2024-06-30 13F GALECTIN THERAPEUTICS CALL Call 5,300 76.67 0 n/a n/a n/a
2024-04-25 2024-03-31 13F GALECTIN THERAPEUTICS CALL Call 3,000 76.47 0 n/a n/a n/a
2024-02-02 2023-12-31 13F GALECTIN THERAPEUTICS CALL Call 1,700 -79.76 0 n/a n/a n/a
2023-11-01 2023-09-30 13F GALECTIN THERAPEUTICS CALL Call 8,400 -4.55 0 n/a n/a n/a
2023-08-04 2023-06-30 13F GALECTIN THERAPEUTICS CALL Call 8,800 -19.27 0 n/a n/a n/a
2023-04-27 2023-03-31 13F GALECTIN THERAPEUTICS CALL Call 10,900 136.96 0 n/a n/a n/a
2023-02-02 2022-12-31 13F GALECTIN THERAPEUTICS CALL Call 4,600 -71.25 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F GALECTIN THERAPEUTICS CALL Call 16,000 61.62 26 116.67 n/a n/a n/a
2022-08-03 2022-06-30 13F GALECTIN THERAPEUTICS CALL Call 9,900 -52.17 12 -63.64 n/a n/a n/a
2022-05-02 2022-03-31 13F GALECTIN THERAPEUTICS CALL Call 20,700 -28.62 33 -45.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A GALECTIN THERAPEUTICS CALL Call 29,000 -33.64 60 -57.75 n/a n/a n/a
2022-02-04 2021-12-31 13F GALECTIN THERAPEUTICS CALL Call 43,700 142 n/a n/a n/a
2021-10-28 2021-09-30 13F GALECTIN THERAPEUTICS CALL Call 43,700 0.00 142 2.16 n/a n/a n/a
2021-08-12 2021-06-30 13F GALECTIN THERAPEUTICS CALL Call 43,700 15,341.70 139 127.87 n/a n/a n/a
2021-04-26 2021-03-31 13F GALECTIN THERAPEUTICS CALL Call 283 -49.64 61 -51.20 n/a n/a n/a
2021-02-02 2020-12-31 13F GALECTIN THERAPEUTICS CALL Call 562 13.08 125 -5.30 n/a n/a n/a
2020-10-14 2020-09-30 13F GALECTIN THERAPEUTICS CALL Call 497 129.03 132 100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F GALECTIN THERAPEUTICS CALL Call 217 -26.94 66 13.79 n/a n/a n/a
2020-04-29 2020-03-31 13F GALECTIN THERAPEUTICS CALL Call 297 -4.50 58 -34.09 n/a n/a n/a
2020-02-05 2019-12-31 13F GALECTIN THERAPEUTICS CALL Call 311 -4.89 88 -26.67 n/a n/a n/a
2019-10-15 2019-09-30 13F GALECTIN THERAPEUTICS CALL Call 327 -0.61 120 -11.76 n/a n/a n/a
2019-07-26 2019-06-30 13F GALECTIN THERAPEUTICS CALL Call 329 -9.37 136 -26.49 n/a n/a n/a
2019-04-18 2019-03-31 13F GALECTIN THERAPEUTICS CALL Call 363 785.37 185 1,221.43 n/a n/a n/a
2019-01-16 2018-12-31 13F GALECTIN THERAPEUTICS CALL Call 41 -95.60 14 -97.50 n/a n/a n/a
2018-10-23 2018-09-30 13F GALECTIN THERAPEUTICS CALL Call 932 167.05 560 153.39 n/a n/a n/a
2018-07-30 2018-06-30 13F GALECTIN THERAPEUTICS CALL Call 349 -1.13 221 262.30 n/a n/a n/a
2018-04-26 2018-03-31 13F GALECTIN THERAPEUTICS CALL Call 353 112.65 61 281.25 n/a n/a n/a
2018-01-10 2017-12-31 13F GALECTIN THERAPEUTICS CALL Call 166 155.38 16 433.33 n/a n/a n/a
2017-10-25 2017-09-30 13F GALECTIN THERAPEUTICS CALL Call 65 14.04 3 50.00 n/a n/a n/a
2017-07-12 2017-06-30 13F GALECTIN THERAPEUTICS CALL Call 57 714.29 2 -33.33 n/a n/a n/a
2017-04-21 2017-03-31 13F GALECTIN THERAPEUTICS CALL Call 7 -97.00 0 -100.00 n/a n/a n/a
2017-01-11 2016-12-31 13F GALECTIN THERAPEUTICS CALL Call 233 -37.03 4 0.00 n/a n/a n/a
2016-10-07 2016-09-30 13F GALECTIN THERAPEUTICS CALL Call 370 444.12 4 300.00 n/a n/a n/a
2016-07-18 2016-06-30 13F GALECTIN THERAPEUTICS CALL Call 68 580.00 1 -75.00 n/a n/a n/a
2016-04-14 2016-03-31 13F GALECTIN THERAPEUTICS CALL Call 10 0.00 0 -100.00 n/a n/a n/a
2016-01-20 2015-12-31 13F GALECTIN THERAPEUTICS CALL Call 10 0.00 0 n/a n/a n/a
2015-10-08 2015-09-30 13F GALECTIN THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2015-07-08 2015-06-30 13F GALECTIN THERAPEUTICS CALL Call 30 0 n/a n/a n/a
2015-04-21 2015-03-31 13F GALECTIN THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2015-03-04 2014-12-31 13F GALECTIN THERAPEUTICS CALL Call 49 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F GALECTIN THERAPEUTICS PUT Put 7,300 21.67 20 -16.67 n/a n/a n/a
2026-02-11 2025-12-31 13F GALECTIN THERAPEUTICS PUT Put 6,000 -88.30 25 n/a n/a n/a
2025-11-12 2025-09-30 13F GALECTIN THERAPEUTICS PUT Put 51,300 -14.36 0 n/a n/a n/a
2025-08-05 2025-06-30 13F GALECTIN THERAPEUTICS PUT Put 59,900 69.21 0 n/a n/a n/a
2025-05-12 2025-03-31 13F GALECTIN THERAPEUTICS PUT Put 35,400 -91.81 0 n/a n/a n/a
2025-02-11 2024-12-31 13F GALECTIN THERAPEUTICS PUT Put 432,200 13,406.25 1 n/a n/a n/a
2024-11-08 2024-09-30 13F GALECTIN THERAPEUTICS PUT Put 3,200 433.33 0 n/a n/a n/a
2024-07-25 2024-06-30 13F GALECTIN THERAPEUTICS PUT Put 600 -91.43 0 n/a n/a n/a
2024-04-25 2024-03-31 13F GALECTIN THERAPEUTICS PUT Put 7,000 -24.73 0 n/a n/a n/a
2024-02-02 2023-12-31 13F GALECTIN THERAPEUTICS PUT Put 9,300 -6.06 0 n/a n/a n/a
2023-11-01 2023-09-30 13F GALECTIN THERAPEUTICS PUT Put 9,900 0.00 0 n/a n/a n/a
2023-08-04 2023-06-30 13F GALECTIN THERAPEUTICS PUT Put 9,900 -7.48 0 n/a n/a n/a
2023-04-27 2023-03-31 13F GALECTIN THERAPEUTICS PUT Put 10,700 -78.60 0 n/a n/a n/a
2023-02-02 2022-12-31 13F GALECTIN THERAPEUTICS PUT Put 50,000 54.32 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F GALECTIN THERAPEUTICS PUT Put 32,400 -33.47 52 -17.46 n/a n/a n/a
2022-08-03 2022-06-30 13F GALECTIN THERAPEUTICS PUT Put 48,700 188.17 63 133.33 n/a n/a n/a
2022-05-02 2022-03-31 13F GALECTIN THERAPEUTICS PUT Put 16,900 186.44 27 125.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A GALECTIN THERAPEUTICS PUT Put 5,900 -74.46 12 -84.00 n/a n/a n/a
2022-02-04 2021-12-31 13F GALECTIN THERAPEUTICS PUT Put 23,100 75 n/a n/a n/a
2021-10-28 2021-09-30 13F GALECTIN THERAPEUTICS PUT Put 23,100 0.00 75 2.74 n/a n/a n/a
2021-08-12 2021-06-30 13F GALECTIN THERAPEUTICS PUT Put 23,100 12,386.49 73 82.50 n/a n/a n/a
2021-04-26 2021-03-31 13F GALECTIN THERAPEUTICS PUT Put 185 -33.21 40 -35.48 n/a n/a n/a
2021-02-02 2020-12-31 13F GALECTIN THERAPEUTICS PUT Put 277 45.79 62 24.00 n/a n/a n/a
2020-10-14 2020-09-30 13F GALECTIN THERAPEUTICS PUT Put 190 68.14 50 47.06 n/a n/a n/a
2020-07-13 2020-06-30 13F GALECTIN THERAPEUTICS PUT Put 113 -4.24 34 47.83 n/a n/a n/a
2020-04-29 2020-03-31 13F GALECTIN THERAPEUTICS PUT Put 118 -11.94 23 -39.47 n/a n/a n/a
2020-02-05 2019-12-31 13F GALECTIN THERAPEUTICS PUT Put 134 32.67 38 2.70 n/a n/a n/a
2019-10-15 2019-09-30 13F GALECTIN THERAPEUTICS PUT Put 101 -23.48 37 -31.48 n/a n/a n/a
2019-07-26 2019-06-30 13F GALECTIN THERAPEUTICS PUT Put 132 88.57 54 54.29 n/a n/a n/a
2019-04-18 2019-03-31 13F GALECTIN THERAPEUTICS PUT Put 70 -69.57 35 -55.13 n/a n/a n/a
2019-01-16 2018-12-31 13F GALECTIN THERAPEUTICS PUT Put 230 -7.63 78 -47.65 n/a n/a n/a
2018-10-23 2018-09-30 13F GALECTIN THERAPEUTICS PUT Put 249 97.62 149 86.25 n/a n/a n/a
2018-07-30 2018-06-30 13F GALECTIN THERAPEUTICS PUT Put 126 10.53 80 1,233.33 n/a n/a n/a
2018-04-26 2018-03-31 13F GALECTIN THERAPEUTICS PUT Put 114 40.74 6 -92.50 n/a n/a n/a
2018-01-10 2017-12-31 13F GALECTIN THERAPEUTICS PUT Put 81 0.00 0 -100.00 n/a n/a n/a
2017-10-25 2017-09-30 13F GALECTIN THERAPEUTICS PUT Put 81 -13.83 6 -25.00 n/a n/a n/a
2017-07-12 2017-06-30 13F GALECTIN THERAPEUTICS PUT Put 94 308.70 8 166.67 n/a n/a n/a
2017-04-21 2017-03-31 13F GALECTIN THERAPEUTICS PUT Put 23 -75.53 3 -62.50 n/a n/a n/a
2017-01-11 2016-12-31 13F GALECTIN THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-10-07 2016-09-30 13F GALECTIN THERAPEUTICS PUT Put 53 307.69 7 0.00 n/a n/a n/a
2016-07-18 2016-06-30 13F GALECTIN THERAPEUTICS PUT Put 13 -48.00 7 -53.33 n/a n/a n/a
2016-04-14 2016-03-31 13F GALECTIN THERAPEUTICS PUT Put 25 92.31 15 114.29 n/a n/a n/a
2015-04-21 2015-03-31 13F GALECTIN THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-03-04 2014-12-31 13F GALECTIN THERAPEUTICS PUT Put 97 89 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.